This independent HPLC-UV/VIS lab test confirms Tirzepatide 30mg from Licensed Peptides at >99.80% purity. The analysis was conducted by a third-party ISO 17025:2017 accredited laboratory and reported on February 11, 2026. The tested quantity measured 30.31 mg against a stated label claim of 30 mg, under Lot No. L10091.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, glycemic control, and weight management. Endotoxin testing passed at <5.33 EU/mg via the LAL method.
The full certificate of analysis and HPLC chromatogram are available for review on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.